Buy Gamavit Injection Online

Gamavit Injection is a veterinary injectable product developed for use in animals and birds as a combined immunomodulatory preparation. The manufacturer’s published information describes Gamavit as a sterile red injectable solution containing sodium nucleinate and an acid hydrolysate of emulsified denatured placenta (EDP) as its active ingredients.

The product is associated with veterinary applications involving innate immune support, recovery, stress resistance, and reduction of the effects of intoxication. The manufacturer’s documentation also describes use in animals exposed to transportation, training, exhibitions, competitions, and other forms of physiological or technological stress.

Gamavit is produced under the Micro-Plus product documentation, with GamaVetFarm identified as the manufacturer in Russian veterinary references. The published Russian authorization information identifies marketing authorization 77-3-5.14-2020 № ПВР-3-3.3/01313.

For international buyers, it is important to distinguish the manufacturer’s Russian veterinary documentation from authorization in other countries. A veterinary product’s registration in one jurisdiction does not automatically establish authorization in the United States, Canada, Australia, the European Union, or another country.

What the Focus Keyword is

Gamavit Injection is the exact focus keyword for this product page.

Gamavit is described by its developer as a sterile solution for injection containing sodium nucleinate and acid hydrolysate of emulsified denatured placenta. The published formulation also includes Medium 199 and water for injection.

The manufacturer’s English documentation states that Gamavit is used to enhance innate immunity, adjust the immune system, and reduce the effects of intoxication in animals and birds. It classifies the product among combined immunomodulatory veterinary preparations.

Gamavit is available in 6 ml, 10 ml, and 100 ml glass vials, according to the manufacturer’s product information.

Because Gamavit is an injectable veterinary product, customers should verify the exact presentation and current labeling before purchase. Different markets may have different packaging, regulatory requirements, distributors, and product documentation.

Gamavit Injection Overview

Product characteristic	Information
Product name	Gamavit
Focus keyword	Gamavit Injection
Product form	Sterile solution for injection
Appearance	Clear red liquid
Active ingredient 1	Sodium nucleinate
Active ingredient 2	Acid hydrolysate of emulsified denatured placenta (EDP)
Sodium nucleinate concentration	0.02 mg/ml
EDP concentration	0.50 mg/ml
Other formulation component	Medium 199, 10× concentrate
Vehicle	Water for injection
Presentations	6 ml, 10 ml, 100 ml
Developer	ZAO Micro-Plus
Manufacturer information	GamaVetFarm / Micro-Plus documentation
Veterinary category	Combined immunomodulatory preparation
Published registration	77-3-5.14-2020 № ПВР-3-3.3/01313
Storage	2°C–25°C, protected from direct sunlight
Shelf life	2 years when stored as directed
Product color	Clear red
International authorization	Must be verified by country

The formulation and storage information above comes from manufacturer documentation.

What Is Gamavit Injection?

Gamavit Injection is a veterinary preparation developed around two principal active components:

• Sodium nucleinate
• Acid hydrolysate of emulsified denatured placenta (EDP)

The manufacturer’s documentation identifies Gamavit as a combined immunomodulatory drug and describes its purpose as supporting innate resistance, modulating immune function, and reducing the consequences of intoxication.

The product is not described simply as a vitamin injection. Its formulation is based on a combination of nucleinate and placental hydrolysate together with a nutrient medium and water for injection.

That distinction is useful when researching the product because online listings sometimes place Gamavit alongside vitamins, biotonics, metabolic preparations, and other animal-health products.

Sterile injectable formulation

The manufacturer identifies Gamavit as a sterile solution for injection.

The product is described as a transparent red liquid and is supplied in glass vials sealed with rubber stoppers and aluminum caps.

This means appropriate product storage, packaging integrity, expiry-date verification, and professional handling are important considerations.

Gamavit Injection Composition

The manufacturer’s published composition states that each 1 ml contains:

Sodium nucleinate — 0.02 mg

Sodium nucleinate is one of the two named active ingredients in Gamavit.

Acid hydrolysate of emulsified denatured placenta — 0.50 mg

The second named active ingredient is an acid hydrolysate of emulsified denatured placenta, abbreviated EDP in the manufacturer’s English documentation.

Medium 199

The formulation also contains Medium 199, 10× concentrate, at 0.1 ml per ml of finished product according to the manufacturer’s English documentation.

Water for injection

Water for injection completes the formulation to the stated volume.

The Russian manufacturer documentation likewise lists sodium nucleinate at 0.02 mg/ml and acid hydrolysate of emulsified denatured placenta at 0.50 mg/ml, with Medium 199 and water for injection as auxiliary components.

Key Product Characteristics

Several characteristics distinguish Gamavit Injection from a conventional oral nutritional supplement.

Injectable veterinary formulation

Gamavit is specifically supplied as a sterile injectable solution rather than as a tablet, powder, paste, or ordinary oral supplement.

Combined composition

The product contains two named active ingredients rather than a single conventional vitamin or mineral.

Red transparent appearance

The manufacturer’s documentation describes the product as a clear red liquid.

A change in appearance can therefore be important. The manufacturer’s instructions state that product with changed color, impurities, or other signs of deterioration should not be used.

Multiple vial sizes

Gamavit is documented in:

• 6 ml
• 10 ml
• 100 ml

glass-vial presentations.

This gives customers different presentation options depending on the animal, veterinary program, and local availability.

Veterinary Applications

The manufacturer’s documentation describes Gamavit for veterinary use in animals and birds.

Its stated purposes include:

• Enhancing innate resistance
• Immune-system adjustment
• Reducing consequences associated with intoxication
• Supporting animals exposed to excessive loads or stress
• Supporting animals during recovery periods
• Certain applications associated with infectious and parasitic disease management
• Support during specific reproductive and obstetric contexts
• Support associated with vaccination and transportation

These are descriptions contained in the manufacturer’s veterinary instructions rather than independent conclusions about efficacy for every animal or condition.

Gamavit is not a replacement for disease-specific treatment

One of the most important distinctions is that Gamavit’s published uses include applications alongside therapeutic agents in certain disease contexts.

For example, the manufacturer’s instructions describe its use in infectious and parasitic diseases as part of a broader therapeutic approach rather than as a replacement for disease-specific treatment.

This means a diagnosis should not be replaced by simply selecting an immunomodulatory product.

Gamavit Injection and Equine Care

Gamavit has relevance to equine customers because product listings and veterinary documentation place it among preparations used across multiple animal species, while commercial veterinary references specifically list horses among the animals for which Gamavit is offered.

The manufacturer’s broader instructions describe applications involving animals subjected to:

• Training
• Transportation
• Exhibitions
• Competitions
• Other excessive or technological loads

The Russian instructions specifically describe use in connection with increased loads and stress associated with preparation for exhibitions and competitions.

For horse owners and trainers, this makes the product particularly relevant when researching veterinary support during periods of increased physical or environmental stress.

However, stress support should not be interpreted as proof that Gamavit enhances athletic performance.

A horse’s performance depends on many factors, including conditioning, nutrition, hydration, musculoskeletal health, respiratory health, cardiovascular function, recovery, and overall veterinary status.

Stress, Transport and Competition Context

The manufacturer’s documentation describes Gamavit as being used to increase resistance to technological stress, including transportation and preparation for exhibitions and competitions.

This is an important distinction from describing the product as a performance-enhancing drug.

A horse may experience physiological stress from:

• Long-distance transportation
• Changes in environment
• Training
• Competition
• Handling
• Vaccination
• Changes in feeding routine
• Separation from familiar animals
• Recovery following illness

Veterinary support during these circumstances should be individualized.

Competition rules still apply

The fact that a product is marketed or used in connection with competition preparation does not automatically establish that it is permitted by every racing authority.

Competitors should verify the current rules applicable to their specific:

• Racing jurisdiction
• Equestrian discipline
• Competition
• Governing organization
• Medication policy

Product legality and competition eligibility are separate questions.

Benefits and Product Considerations

The manufacturer’s stated product profile provides several areas of interest.

Immune-support context

Gamavit is described as an immunomodulatory preparation intended to support innate resistance and adjust immune function.

Stress-support context

The manufacturer’s instructions associate the product with resistance to stress and excessive loads.

Recovery context

Published instructions describe applications involving animals recovering after disease or surgery.

Intoxication-support context

Gamavit is also described for reducing the consequences of intoxication.

Broad veterinary application

The product documentation describes use in animals and birds rather than limiting it to a single species.

Important limitation

These points describe the product’s documented intended uses. They should not be converted into guarantees of clinical benefit for an individual horse.

Safety Information

The manufacturer’s instructions identify increased individual sensitivity to the product’s components as a contraindication.

The manufacturer reports that no side effects or complications were generally observed when Gamavit was used according to the instructions, while also directing that the product be discontinued and appropriate symptomatic treatment provided if an allergic reaction occurs.

This information should not be interpreted as meaning that an individual animal cannot experience an adverse reaction.

Veterinary assessment remains important

Before using an injectable veterinary product, consideration should be given to:

• Species
• Age
• Medical history
• Current medications
• Current illness
• Pregnancy or lactation
• Hydration status
• Previous reactions to veterinary medicines
• Competition status
• Local regulatory requirements

A veterinarian is best placed to determine whether Gamavit is appropriate for a particular animal.

Contraindications and Precautions

The published manufacturer information identifies hypersensitivity to the components as a contraindication.

Customers should also carefully examine the product before use.

Do not use a vial if:

• The product is beyond its expiry date
• The color has changed
• Visible impurities are present
• Packaging integrity has been compromised
• The identity of the product cannot be confirmed
• Storage conditions are unknown or clearly unsuitable

The manufacturer’s instructions specifically state that expired, altered-color, or contaminated-looking product should be disposed of in accordance with applicable requirements.

Storage and Handling

The manufacturer provides specific storage requirements for Gamavit.

The product should be stored:

• In the original sealed packaging
• At 2°C to 25°C
• In a dry location
• Away from direct sunlight
• Away from food and animal feed
• Away from unauthorized access
• Out of reach of children

The stated shelf life is two years from the manufacturing date when the product is stored according to the specified conditions.

After opening

The Russian manufacturer instructions state that Gamavit should not be stored after opening.

This is particularly important for customers purchasing larger vials. The presence of a larger presentation does not mean that an opened vial can automatically be retained for later use.

Protect the product from sunlight

Gamavit is a red solution and the manufacturer’s storage instructions specifically require protection from direct sunlight.

Customers should therefore retain the product in its original packaging until needed.

Packaging and Presentation

The documented presentations are:

Gamavit 6 ml

A small-vial presentation suitable for situations where a lower-volume package is appropriate.

Gamavit 10 ml

A mid-sized presentation commonly encountered in veterinary product catalogs.

Gamavit 100 ml

The largest of the manufacturer’s documented standard vial presentations.

Exact packaging and availability may vary between distributors and countries.

When ordering internationally, customers should confirm the precise vial size rather than relying solely on a product title.

Manufacturer and Product Background

Gamavit was developed by ZAO Micro-Plus, based in Moscow. The manufacturer’s English product documentation identifies Micro-Plus as the product developer.

Veterinary registration references identify GamaVetFarm as the manufacturer associated with the product and list the same veterinary registration number, ПВР-3-3.3/01313.

The manufacturer’s website states that the product is recommended for authorization in the Russian Federation through the relevant veterinary quality and standardization authority and provides the marketing authorization number.

Regulatory and International Considerations

Gamavit’s regulatory information should be interpreted in the context of the country where the product is being purchased or used.

A Russian veterinary authorization does not automatically mean that Gamavit is registered as a veterinary medicine in every other market.

United States

Customers in the United States should verify the status of the exact Gamavit product and formulation under applicable U.S. veterinary-drug requirements before purchasing or importing it.

Canada

Canadian buyers should verify applicable Canadian requirements for veterinary medicinal products and imported animal-health products.

Australia

Australian customers should verify the relevant requirements before importing or using Gamavit, including whether the exact product is authorized or otherwise lawfully available.

European Union

Availability through an international seller should not be interpreted as proof of EU-wide veterinary authorization.

South Africa and other international markets

Customers should verify local veterinary-medicine requirements before importing or using the product.

International availability and legal authorization are not the same thing.

Purchasing Gamavit Injection

When purchasing Gamavit Injection, customers should check several details before completing an order.

Verify the exact product

Confirm that the product is specifically Gamavit and not a similarly named veterinary preparation.

Confirm the vial size

The manufacturer’s documented presentations include 6 ml, 10 ml, and 100 ml.

Check the packaging

The vial should be properly sealed and clearly labeled.

Check expiry information

Do not purchase or use product with an unclear or expired date.

Examine product appearance

The manufacturer’s documentation describes Gamavit as a clear red solution. Any unexpected color change or visible impurities should be treated as a reason not to use the product.

Consider local regulations

Before importing an injectable veterinary medicine, verify whether your country requires veterinary authorization, import documentation, registration, or other regulatory procedures.

Where To Buy Gamavit Injection Online

If you are looking for where to buy Gamavit Injection online, the safest approach is to verify the product before comparing price or delivery options.

World Equine Vet can provide product information for customers researching Gamavit, but customers should independently confirm that the exact presentation offered is appropriate for their location and intended veterinary use.

Before ordering, check:

• Exact product name
• Manufacturer
• Vial size
• Active ingredients
• Expiry date
• Batch identification
• Packaging integrity
• Storage conditions
• Country of origin
• Local import requirements
• Veterinary requirements
• Competition medication rules where relevant

Gamavit is an injectable veterinary product, so product traceability is more important than simply selecting the lowest advertised price.

Why Choose World Equine Vet?

At World Equine Vet, product information is designed to help equine owners, trainers, veterinary professionals, and animal-care customers understand what they are researching before purchasing.

For Gamavit Injection, that means clearly identifying the documented formulation, presentation, manufacturer information, storage requirements, and intended veterinary context rather than treating broad online marketing claims as universal guarantees.

Customers can use the product information to compare:

• Formulation
• Presentation
• Intended context
• Storage requirements
• Manufacturer information
• Regulatory considerations
• Competition considerations

The final decision about veterinary treatment should remain with the responsible animal owner and qualified veterinary professional.

Frequently Asked Questions

What is Gamavit Injection?

Gamavit Injection is a sterile veterinary injectable solution described by its developer as a combined immunomodulatory preparation for animals and birds. Its documented active ingredients are sodium nucleinate and acid hydrolysate of emulsified denatured placenta.

What are the active ingredients in Gamavit?

Each 1 ml contains 0.02 mg sodium nucleinate and 0.50 mg acid hydrolysate of emulsified denatured placenta. The formulation also contains Medium 199 and water for injection.

What color is Gamavit Injection?

The manufacturer’s documentation describes Gamavit as a clear red liquid.

What sizes does Gamavit come in?

The documented presentations are 6 ml, 10 ml, and 100 ml glass vials.

Is Gamavit used in horses?

Gamavit is marketed and documented for use across multiple animal species, and veterinary product listings specifically identify horses among the species associated with the product.

For an individual horse, suitability should be assessed by a veterinarian.

What is Gamavit used for?

The manufacturer describes Gamavit for enhancing innate resistance, immune-system adjustment, and reducing the effects of intoxication. Its veterinary instructions also describe applications associated with stress, recovery, infectious and parasitic disease management, and certain reproductive contexts.

Is Gamavit a vitamin injection?

Gamavit is better described as a combined immunomodulatory veterinary preparation. Its two named active ingredients are sodium nucleinate and acid hydrolysate of emulsified denatured placenta; the formulation also contains Medium 199.

Does Gamavit improve horse performance?

The manufacturer’s documentation discusses use around excessive loads, training, transportation, exhibitions, and competitions, but this should not be interpreted as a guarantee of improved athletic performance.

Is Gamavit legal for competition horses?

Competition eligibility depends on the rules of the relevant racing or equestrian authority. A product’s veterinary-market availability does not automatically establish competition eligibility.

How should Gamavit be stored?

The manufacturer specifies storage in the original sealed packaging at 2°C to 25°C, in a dry location protected from direct sunlight.

Can opened Gamavit be stored?

The Russian manufacturer instructions state that Gamavit should not be stored after the vial has been opened.

What is the shelf life of Gamavit?

The manufacturer’s documentation gives a shelf life of two years from the date of manufacture when stored under the specified conditions.

Is Gamavit available internationally?

Gamavit appears through international veterinary-product sellers, but availability does not establish authorization in every country. Buyers should check their local regulatory requirements before importing or using the product.

Is Gamavit prescription-only?

The Russian manufacturer documentation states that the product is dispensed without a veterinary prescription under the cited Russian instructions.

That classification should not automatically be applied to other countries, where veterinary medicines may have different legal categories.

Who developed Gamavit?

The manufacturer documentation identifies ZAO Micro-Plus as the product developer.

What is the Gamavit registration number?

The manufacturer’s documentation identifies marketing authorization 77-3-5.14-2020 № ПВР-3-3.3/01313.

Final Summary

Gamavit Injection is a documented veterinary injectable preparation containing sodium nucleinate 0.02 mg/ml and acid hydrolysate of emulsified denatured placenta 0.50 mg/ml, together with Medium 199 and water for injection.

The product is supplied as a clear red sterile solution in 6 ml, 10 ml, and 100 ml glass vials. The manufacturer’s documentation describes Gamavit as a combined immunomodulatory preparation intended to support innate resistance, adjust immune function, and reduce the effects of intoxication in animals and birds.

Its published veterinary context also includes animals experiencing stress or excessive loads, including transportation, training, exhibitions, and competitions. These descriptions should be understood as the manufacturer’s stated uses rather than a guarantee of performance enhancement.

For equine customers, the most important considerations are product identity, veterinary suitability, storage, country-specific regulatory status, and competition rules.

Gamavit should be stored at 2°C–25°C, protected from direct sunlight and kept in its original packaging. The manufacturer states that opened product should not be stored for later use.

World Equine Vet recommends verifying the exact presentation and current product documentation before purchase, particularly when ordering internationally.

 

Gamavit contains a complex of biologically active substances, thanks to which it optimizes metabolic processes in the body (in particular, protein, vitamin and mineral), normalizes the blood formula, increases the bactericidal activity of blood serum, has an immunomodulatory and general biotonizing effect. It is a biogenic stimulant and adaptogen, reduces postnatal mortality, increases the viability of offspring, increases muscle performance and resistance of animals to increased stress and stress. It is a source of substrates for metabolism, promotes growth.

Indications
The drug is used for the prevention and treatment of various diseases as a biotonizing agent: for anemia, hypovitaminosis, for infectious and invasive diseases, pyometra, for poisoning, in the postoperative period, for toxicosis of pregnancy, childbirth, in preparing animals for exhibitions, competitions and transportation.

 

Doses and method of administration
The drug is administered subcutaneously, intramuscularly, intravenously, possibly by drinking.

For the purpose of prophylaxis, Gamavit is administered at 0.1 ml / kg of body weight of the animal (prophylactic dose).

For therapeutic purposes – 0.3-0.5 ml / kg (therapeutic dose).

In order to prevent: anemia, hypovitaminosis, weakened, old animals, during the recovery period after diseases and operations, the drug is prescribed intramuscularly 1-3 times a week. The duration of the course is on average 2-4 weeks or more. At increased loads, to enhance the resistance of animals to technological stress, the drug is administered before stressful exposure once or a course 8, 6, 4 days before and immediately before exposure to stress factors.

To increase fertility, Gamavit should be administered at a dose of 0.025-0.05 ml / kg on the day of fertilization, to facilitate childbirth and prevent postpartum complications – at the same dose 1 week before and during childbirth.

To prevent early mortality, malnutrition, to increase resistance to diseases and weight gain, the drug is administered to newborns on days 1, 3 and 5 or 7 of life at a dose of 0.1 ml / kg.

With a therapeutic purpose: in the treatment of infectious and invasive diseases (including piroplasmosis), the drug is administered as part of a complex of standard therapy means 2-3 times a day for 3-5 days. In case of poisoning, Gamavit is administered subcutaneously, intravenously or by drip 1 time in a 3-5-fold therapeutic dose as part of a complex of standard therapy. In case of feeding disorders, growth retardation and intoxication, Gamavit is administered 1 time a day for 5-7 days.

For deworming, Gamavit is used in conjunction with anthelmintic agents. The drug is administered intramuscularly on the day of deworming and again every other day. In the treatment of obstetric and gynecological diseases, Gamavit is used as part of a complex of standard therapy once a day for 5-7 days, in pathological childbirth – once in a double therapeutic dose. Gamavit combines well with other pharmacological agents. The combination with Fosprenil enhances the effect of the drug.

 

Side effects Side
effects and complications after the use of Gamavit have not been established.

 

Contraindications
Not established.

 

Special instructions
None.

 

Storage conditions
Store the drug at a temperature of 4 ° C to 25 ° C, avoiding freezing. Shelf life – 1 year from the date of production. The drug in vials with impaired integrity, with turbidity or discoloration, the presence of foreign impurities, with an expired shelf life or violation of storage and transportation conditions is not suitable for use.